Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (5408)	6/21/1999 10:19:00 PM
From: JanyBlueEyes	Read Replies (1) \| Respond to of 5736

WRONG WAY WEXLER Let me clean off the dust and cobwebs from the CCSI archive and fill you in on a fundamental difference in the two devices (which was also stated in the conference call today): From the most recent 10K filed with the SEC - CCSI: sec.gov "The Company has developed a ColorMate(Registered) non-invasive transcutaneous bilirubinometer device for monitoring newborn bilirubinemia(infant jaundice) in infants of all races including when under phototherapy." Now go check out Spectrx's 10K. Their device CAN NOT be used once the baby undergoes phototherapy treatment. What an OLD OLD SHORT STORY <<<<<<YAWN>>>>>>>>

To: Bill Wexler who wrote (5408)	6/21/1999 11:02:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 5736

The CCSI stock fraud and razor blades... One of the more misleading tactics of the CCSI stock fraud is the comparison of CCSI's generic colorimeter and a disposable "lensette" to a razor and razor blade. CCSI states that it won't really make money from the machines themselves, but from sales of its disposable cover which will generate income stream like an "annuity" (as stated in the conference call). This "recalibration" cover has to be changed supposedly every time it comes into contact with a new patient's skin. CCSI stock promoters have bandied a price of $10 per lensette. Of course, during the conference call Darby McFarlane refused to give any specific details of actual pricing...calling that information "secret". Current bilirubin blood tests are safe, effective, extremely accurate, and most importantly...very, very cheap. Even if a colorimeter is used to monitor serum bilirubin levels, blood tests will nearly always be required for jaundiced babies. Darby McFarlane attempts to obfuscate this fact by claiming that CCSI will promote changing diagnostic procedure to a completely "non-invasive" method. Darby McFarlane - con-artist and former cosmetician - is an unlikely candidate to alter well-established pediatric medicine. Even Darby's paid medical consultants have been very careful not to make such sweeping statements. Interesting to note that the following maker of a true "disposable" related to the infant jaundice market, does not seem to agree with the potential market size touted by CCSI stock promoters. It's also clear that this manufacturer is not exactly raking in the big bucks... ktv-i.com bilibottoms.com